Study: Hepatitis C+ Donor Hearts Just as Good
Graft, survival outcomes on par with uninfected transplants at 1 year
Related Articles
Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients
Using OCT to look at the burden, not just individual factors, helps provide clues on why disease develops—and how it manifests.
Finerenone Gets Expanded FDA Approval in Heart Failure
First nonsteroidal mineralocorticoid receptor antagonist OK’d for higher ejection fractions
Kidney Transplantation Without Lifelong Immunosuppression Edges Toward Reality
Three-fourths of patients off immunosuppression at 2 years with donor-derived cellular therapy
Durable Survival Outcomes in Advanced Melanoma With Neoadjuvant Dual Immunotherapy
Most patients alive and recurrence-free after 4 years of follow-up in phase II trial
GLP-1 Therapy Helps Amplify Bariatric Surgery Weight Loss, but Timing Matters
Using an agent only pre- or postoperatively not different than surgery alone
Youth Emergency Visits for Cannabis Vomiting Disorder Spiked in Recent Years
Rates highest in states with recreational cannabis
Bariatric Surgery No Cure for PCOS in Teen Girls
Few experienced remission of PCOS symptoms despite substantial weight loss
Kennedy Abruptly Cancels USPSTF Meeting
Move raises concern that the task force may face a similar fate as CDC’s federal vaccine advisors
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 (HealthDay News) — Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and c
Menopause Hormone Therapy Users May Lose More on Weight Loss Injectable
Users experienced 35% more weight loss than non-users